Helsinn Group supports Satellite Symposium at 10th International Conference on Cachexia, Sarcopenia and Muscle Wasting
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that it is suppo…
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that it is suppo…
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care products, today announces that data on the…
Helsinn, a Swiss pharmaceutical group focused on building quality cancer care, announces that the Group has provided a g…
Nycomed today announced that the European Commission has granted marketing authorisation for Instanyl®, its first-in-cla…
A Phase II study with the trifunctional antibody catumaxomab in the treatment of patients with gastric cancer showed the…